drugset / Trial / NCT00734630

Efficacy and Safety of Nebivolol (Added to Lisinopril or Losartan) in Hypertensive Patients

NCT00734630

Phase 4 Completed 491 enrolled Forest Laboratories
RandomizedParallel-groupDouble-blindTreatment

Summary

This study will assess blood pressure reduction with nebivolol or placebo in patients taking lisinopril or losartan.

Timeline

Start
2008-08
Primary completion
2010-03
Completion
2010-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Nebivolol Other / unclassified 5 mg Oral
Comparator Nebivolol Other / unclassified 10 mg Oral
Comparator Nebivolol Other / unclassified 20 mg Oral
Comparator Nebivolol Other / unclassified 40 mg Oral